SSPN

SSPN (Sarcospan/KRAG) encodes a transmembrane protein whose hydrophobicity profile resembles tetraspanin (transmembrane 4 superfamily) members and is highly expressed in muscle; it was originally identified through co-amplification with KRAS2 at chromosome 12p11.2 (PMID:8661122). In vascular cells, SSPN co-localizes with sarcoglycans and with dystrophin or utrophin, placing it within the sarcoglycan-sarcospan complex on both dystrophin and utrophin scaffolds (PMID:15583476). SSPN expression is controlled epigenetically, with complete DNA methylation of its promoter suppressing transcription in a reporter assay (PMID:29932866). Beyond these observations, the molecular function of SSPN has not been characterized in the available corpus.

1. 1996 Medium

   Established SSPN/KRAG as a candidate tetraspanin-like transmembrane protein and defined its genomic context and tissue expression, framing what kind of molecule it might be.

   Evidence RT-PCR, hydrophobicity analysis, Northern blot, and YAC/multiplex PCR mapping of the human KRAG locus

   PMID:8661122

   Open questions at the time

   • Structure inferred from hydrophobicity prediction only, with no experimental membrane topology
   • No functional reconstitution or mutagenesis
   • Significance of co-amplification with KRAS2 not mechanistically resolved
2. 2004 Low

   Placed SSPN within the sarcoglycan-sarcospan complex in vascular cells by showing co-localization with sarcoglycans and dystrophin/utrophin, extending its complex membership beyond skeletal muscle.

   Evidence RT-PCR, immunofluorescence, and co-localization microscopy in human umbilical cord vessel smooth muscle and endothelial cells

   PMID:15583476

   Open questions at the time

   • Co-localization only, without co-IP or reciprocal physical validation
   • No functional perturbation establishing a role in the complex
   • Stoichiometry and direct binding partners undefined
3. 2018 Low

   Demonstrated epigenetic control of SSPN, showing that promoter DNA methylation silences expression and linking this to metabolic traits.

   Evidence Luciferase reporter assay with methylated SSPN promoter construct, pyrosequencing, and genome-wide methylation/expression data in MCF7 cells

   PMID:29932866

   Open questions at the time

   • Mechanistic claim rests on a single reporter assay; metabolic associations are correlative
   • Methylation-sensitive transcription factors at the promoter not identified
   • Causal link between SSPN silencing and adipose/glucose phenotypes not established

• The molecular activity of SSPN within the sarcoglycan-sarcospan complex remains undefined: how it contributes to complex assembly, scaffold stability, or signaling has not been determined.
• No direct binding assays defining SSPN interaction interfaces
• No loss-of-function phenotype reported in the corpus
• No structural model of the protein